Radix Industries (India) Valuation
Is 531412 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 531412 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 531412 (₹161.4) is trading above our estimate of fair value (₹4.19)
Significantly Below Fair Value: 531412 is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 531412?
Key metric: As 531412 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is 531412's PE Ratio? | |
|---|---|
| PE Ratio | 106.3x |
| Earnings | ₹22.79m |
| Market Cap | ₹2.53b |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 7.1x |
| Enterprise Value/EBITDA | 75.7x |
| PEG Ratio | n/a |
Price to Earnings Ratio vs Peers
How does 531412's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 67.1x | ||
541601 Rajnish Wellness | 162.6x | n/a | ₹1.4b |
530689 Lykis | 34.4x | n/a | ₹811.4m |
542248 Deccan Health Care | 34.9x | n/a | ₹553.4m |
524703 Sandu Pharmaceuticals | 36.5x | n/a | ₹555.7m |
531412 Radix Industries (India) | 106.3x | n/a | ₹2.5b |
Price-To-Earnings vs Peers: 531412 is expensive based on its Price-To-Earnings Ratio (106.3x) compared to the peer average (67.1x).
Price to Earnings Ratio vs Industry
How does 531412's PE Ratio compare vs other companies in the IN Personal Products Industry?
| 0 Companies | Price / Earnings | Estimated Growth | Market Cap |
|---|
| 0 Companies | Estimated Growth | Market Cap |
|---|
Price-To-Earnings vs Industry: 531412 is expensive based on its Price-To-Earnings Ratio (106.3x) compared to the Asian Personal Products industry average (25.2x).
Price to Earnings Ratio vs Fair Ratio
What is 531412's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 106.3x |
| Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 531412's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
Dabur India
₹900.7b
Operates as a fast-moving consumer goods company worldwide.
DABUR
₹508.20
7D
-0.5%
1Y
-6.1%
Jyothy Labs
₹148.6b
Engages in the manufacture and marketing of fabric care, dishwashing, personal care, and household insecticides products in India and internationally.
JYOTHYLAB
₹404.75
7D
-7.2%
1Y
-8.3%
Dabur India
₹900.7b
Operates as a fast-moving consumer goods company worldwide.
500096
₹508.25
7D
-0.5%
1Y
-6.0%